Concepedia

Publication | Closed Access

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

DOI

444

Citations

11

References

1996

Year

Daniel O. Clegg, Domenic J. Reda, Edwin Mejías, Grant W. Cannon, Michael H. Weisman, Thomas H. Taylor, Elly Budiman‐Mak, Warren D. Blackburn, Frank B. Vasey, Maren L. Mahowald,
Arthritis & Rheumatism

Abstract

SSZ at a dosage of 2,000 mg/day is well tolerated and may be more effective than placebo in the treatment of patients with PsA.

References

YearCitations

Page 1